This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Five-Year Survival Rates

Frederic A. Pugliano, MD; Jay F. Piccirillo, MD; Maria R. Zequeira, MD; Bahman Emami, MD; Carlos A. Perez, MD; Joseph R. Simpson, MD; John M. Fredrickson, MD

Arch Otolaryngol Head Neck Surg. 1997;123(10):1118-1124.

Abstract
Objective
To improve the classification and survival estimates for patients with oropharyngeal cancer by combining cancer symptom severity and comorbidity with the current TNM cancer staging system.

Design
Retrospective medical record review using explicit coding criteria.

Setting
University medical center.

Patients and Methods
Two hundred ninety-six patients receiving initial treatment from January 1, 1980, to December 31, 1989. Multivariate analysis identified patient factors that had a significant impact on 5-year survival. These patient factors, symptom severity and comorbidity, were combined with cancer stage to create a composite clinical-severity staging system.

Main Outcome Measure
Five-year survival.

Results
The overall 5-year survival rate was 38% (111/296). Survival by TNM cancer stage was 67% (18/27) for stage I, 46% (24/52) for stage II, 31% (26/85) for stage III, and 32% (43/132) for stage IV (²=10.84; P=.001). When patients were grouped according to the clinical-severity staging system, survival rates were 70% (16 of 23) for stage A, 47% (71 of 152) for stage B, 27% (18 of 67) for stage C, and 11% (6 of 54) for stage D (²=34.49; P=.001).

Conclusions
Survival estimates can be improved by adding carefully studied and suitably defined patient variables to the TNM cancer stage. The current TNM cancer staging system for oropharyngeal cancer is based solely on the morphologic description of the tumor and disregards the clinical condition of the patient. Cancer symptom severity and comorbidity have a significant impact on survival. Continued exclusion of patient factors leads to imprecision in prognostic estimates and hinders interpretation of clinical studies.

Arch Otolaryngol Head Neck Surg. 1997;123:1118-1124

Author Affiliations
From the Departments of Otolaryngology (Drs Pugliano, Piccirillo, Zequeira, and Fredrickson) and Radiation Oncology (Drs Emami, Perez, and Simpson), Washington University School of Medicine, St Louis, Mo.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

APACHE II, POSSUM, and ASA Scores and the Risk of Perioperative Complications in Patients With Oral or Oropharyngeal Cancer
de Cassia Braga Ribeiro and Kowalski
Arch Otolaryngol Head Neck Surg 2003;129:739-745.
ABSTRACT | FULL TEXT  

Perioperative Complications, Comorbidities, and Survival in Oral or Oropharyngeal Cancer
Ribeiro et al.
Arch Otolaryngol Head Neck Surg 2003;129:219-228.
ABSTRACT | FULL TEXT  

Risk Factors for Postoperative Complications in Oral Cancer and Their Prognostic Implications
de Melo et al.
Arch Otolaryngol Head Neck Surg 2001;127:828-833.
ABSTRACT | FULL TEXT  

Impact of Comorbidity, Symptoms, and Patients' Characteristics on the Prognosis of Oral Carcinomas
Ribeiro et al.
Arch Otolaryngol Head Neck Surg 2000;126:1079-1085.
ABSTRACT | FULL TEXT  

Impact of Comorbidity and Symptoms on the Prognosis of Patients With Oral Carcinoma
Piccirillo
Arch Otolaryngol Head Neck Surg 2000;126:1086-1088.
FULL TEXT  

Prognostic Staging System for Recurrent, Persistent, and Second Primary Cancers of the Oral Cavity and Oropharynx
Yueh et al.
Arch Otolaryngol Head Neck Surg 1998;124:975-981.
ABSTRACT | FULL TEXT